Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
11,938.08
+64.04
(+0.54%)
NZD/USD
0.6012
+0.0049
(+0.83%)
NZD/EUR
0.5579
+0.0023
(+0.42%)
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
OIL
77.99
-0.96
(-1.22%)
Matinas BioPharma Holdings, Inc. (MTNB)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.1749
-0.0084
(-4.58%)
At close: 04:00PM EDT
0.1759
+0.00
(+0.57%)
After hours:
07:44PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,125
1,096
3,188
33
158.333
Operating expenses
Research development
17,051
14,489
16,678
14,583
14,359
Selling general and administrative
10,898
10,373
11,100
10,185
10,006
Total operating expenses
27,949
24,862
27,778
24,768
24,365
Operating income or loss
-25,824
-23,766
-24,590
-24,735
-24,207
Total other income/expenses net
1,762
824
3,593
1,452
1,760
Income before tax
-24,062
-22,942
-20,997
-23,283
-22,447
Income from continuing operations
-24,062
-22,942
-20,997
-23,283
-22,447
Net income
-24,062
-22,942
-20,997
-23,283
-22,447
Net income available to common shareholders
-24,062
-22,942
-20,997
-23,679
-23,240
Basic EPS
-0.10
-
-0.10
-0.11
-0.12
Diluted EPS
-0.10
-
-0.10
-0.11
-0.12
Basic average shares
217,166
-
216,811
210,178
196,895
Diluted average shares
217,166
-
216,811
210,178
196,895
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.